About Us

VBL Therapeutics (NASDAQ: VBLT) is developing targeted therapies for people living with
immune-inflammatory diseases

Our expertise in human biology led to the development of our proprietary Monocyte Targeting Technology (MTT), which is designed in a specific way to limit chronic inflammation.